104 related articles for article (PubMed ID: 1716682)
1. Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists.
Shiosaki K; Lin CW; Kopecka H; Tufano MD; Bianchi BR; Miller TR; Witte DG; Nadzan AM
J Med Chem; 1991 Sep; 34(9):2837-42. PubMed ID: 1716682
[TBL] [Abstract][Full Text] [Related]
2. Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.
Shiosaki K; Lin CW; Kopecka H; Craig RA; Bianchi BR; Miller TR; Witte DG; Stashko M; Nadzan AM
J Med Chem; 1992 May; 35(11):2007-14. PubMed ID: 1375964
[TBL] [Abstract][Full Text] [Related]
3. Minor structural differences in Boc-CCK-4 derivatives dictate affinity and selectivity for CCK-A and CCK-B receptors.
Shiosaki K; Lin CW; Kopecka H; Bianchi B; Miller T; Stashko M; Witte D
J Med Chem; 1997 Mar; 40(7):1169-72. PubMed ID: 9089338
[TBL] [Abstract][Full Text] [Related]
4. CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue.
Bennett MJ; Nikkel AL; Bianchi BR; Miller TR; Bednarz L; Witte DG; Stashko M; Wang SS; Gore PA; Asin KE
J Med Chem; 1994 May; 37(11):1569-71. PubMed ID: 8201591
[TBL] [Abstract][Full Text] [Related]
5. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
6. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Corringer PJ; Weng JH; Ducos B; Durieux C; Boudeau P; Bohme A; Roques BP
J Med Chem; 1993 Jan; 36(1):166-72. PubMed ID: 8421283
[TBL] [Abstract][Full Text] [Related]
7. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
[TBL] [Abstract][Full Text] [Related]
8. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.
Bianchi BR; Miller TR; Witte DG; Lin CW
J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
[TBL] [Abstract][Full Text] [Related]
10. CCK-A receptor selective antagonists derived from the CCK-A receptor selective tetrapeptide agonist Boc-Trp-Lys(Tac)-Asp-MePhe-NH2 (A-71623).
Sugg EE; Kimery MJ; Ding JM; Kenakin DC; Miller LJ; Queen KL; Rimele TJ
J Med Chem; 1995 Jan; 38(1):207-11. PubMed ID: 7837233
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
[TBL] [Abstract][Full Text] [Related]
12. Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus.
Elliott RL; Kopecka H; Bennett MJ; Shue YK; Craig R; Lin CW; Bianchi BR; Miller TR; Witte DG; Stashko MA
J Med Chem; 1994 Jan; 37(2):309-13. PubMed ID: 8295219
[TBL] [Abstract][Full Text] [Related]
13. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
[No Abstract] [Full Text] [Related]
14. Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
Dezube M; Sugg EE; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; James MK; Johnson MF; Mosher JT
J Med Chem; 1995 Aug; 38(17):3384-90. PubMed ID: 7650691
[TBL] [Abstract][Full Text] [Related]
15. Biological effects of newly synthesized cholecystokinin analogs.
Verspohl EJ; LaMura M
Horm Res; 2000; 53(4):177-84. PubMed ID: 11044801
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
19. A further analysis of the contraction induced by activation of cholecystokinin A receptors in guinea pig isolated ileum longitudinal muscle-myenteric plexus.
Corsi M; Palea S; Pietra C; Oliosi B; Gaviraghi G; Sugg E; Van Amsterdam FT; Trist DG
J Pharmacol Exp Ther; 1994 Aug; 270(2):734-40. PubMed ID: 7520941
[TBL] [Abstract][Full Text] [Related]
20. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
Menozzi D; Gardner JD; Jensen RT; Maton PN
Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
